gsk3277509a
Vaccineexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02177734)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk3277509a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07053384 | Phase 1 | Jul 10, 2025 | ViiV Healthcare |
| NCT05996471 | Phase 2 | Aug 17, 2023 | ViiV Healthcare |
| NCT05291520 | Phase 1 | Feb 23, 2022 | ViiV Healthcare |
| NCT04871113 | Phase 2 | Jun 22, 2021 | ViiV Healthcare |
| NCT02177734 | Phase 1 | Mar 1, 2016 | GlaxoSmithKline |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ViiV Healthcare | For profit | 4 | 4 | 2 | 2021 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2016 |
2 organizations
Page 1 / 1